Literature DB >> 4027144

The effect of acute and chronic nicardipine therapy on forearm arterial haemodynamics in essential hypertension.

J Levenson, A C Simon, J Bouthier, B C Maarek, M E Safar.   

Abstract

By using simultaneous recording curves obtained with pulsed Doppler velocimetry and strain gauge mechanography, forearm arterial haemodynamics were studied in 26 patients with mild to moderate essential hypertension. Fifteen patients received a single oral dose of nicardipine 40 mg, and 11 patients were treated with nicardipine 30 mg three times daily for 3 months. In both groups of patients there was a similar and significant (P less than 0.001) reduction in mean, systolic, and diastolic pressures. There was a slight increase in heart rate (P less than 0.05) after the single dose, but no change after 3 months of treatment. The diameter, blood velocity, and blood flow of the brachial artery increased significantly in both treatment groups. The decrease in forearm vascular resistance was significant for both treatment groups. Brachial artery compliance increased (P less than 0.01) and characteristic impedance decreased (P less than 0.01) after both single-dose and long-term therapy with nicardipine. In patients who received nicardipine for 3 months, there were close correlations between the baseline serum calcium level and the percent change in vascular resistance (r = -0.73, P less than 0.01), blood flow (r = 0.89, P less than 0.001), and blood velocity (r = 0.91. P less than 0.001) of the forearm. No correlation was found between the baseline serum calcium and the change in arterial pressure. This study provided evidence that the blood-pressure-lowering effect of nicardipine was accompanied by a direct vasodilatory action in the small and large arteries of the forearm. An increase in peripheral blood flow with concomitant improvement of arterial compliance are the consequences of these arterial actions.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4027144      PMCID: PMC1400789          DOI: 10.1111/j.1365-2125.1985.tb05151.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  20 in total

1.  Hypertension in hyperparathyroidism.

Authors:  J HELLSTROM; G BIRKE; C A EDVALL
Journal:  Br J Urol       Date:  1958-03

2.  Experimental cerebral vasospasm in cats: modification by a new synthetic vasodilator YC-93.

Authors:  Y Handa; S Yoneda; T Koyama; M Matsuda; H Handa
Journal:  Surg Neurol       Date:  1975-04

3.  Pharmacological evaluation of YC-93, a new vasodilator, in healthy volunteers.

Authors:  T Seki; T Takenaka
Journal:  Int J Clin Pharmacol Biopharm       Date:  1977-06

4.  Blood pressure effects of acute hypercalcemia. Studies in patients with chronic renal failure.

Authors:  P Weidmann; S G Massry; J W Coburn; M H Maxwell; J Atleson; C R Kleeman
Journal:  Ann Intern Med       Date:  1972-05       Impact factor: 25.391

5.  Correlation of platelet calcium with blood pressure. Effect of antihypertensive therapy.

Authors:  P Erne; P Bolli; E Bürgisser; F R Bühler
Journal:  N Engl J Med       Date:  1984-04-26       Impact factor: 91.245

6.  Cerebrovascular effects of YC-93, a new vasodilator, in dogs, monkeys and human patients.

Authors:  T Takenaka; J Handa
Journal:  Int J Clin Pharmacol Biopharm       Date:  1979-01

7.  Baroreflex setting and sensitivity after acute and chronic nicardipine therapy.

Authors:  M A Young; R D Watson; W A Littler
Journal:  Clin Sci (Lond)       Date:  1984-02       Impact factor: 6.124

8.  Blood pressure in subjects with hypercalcaemia and primary hyperparathyroidism detected in a health screening programme.

Authors:  T Christensson; K Hellström; B Wengle
Journal:  Eur J Clin Invest       Date:  1977-04       Impact factor: 4.686

9.  The effect of a new calcium channel blocker nicardipine on 24-hour ambulatory blood pressure and the pressor response to isometric and dynamic exercise.

Authors:  R I Jones; R S Hornung; T Sonecha; E B Raftery
Journal:  J Hypertens       Date:  1983-06       Impact factor: 4.844

10.  Enhanced vasodilatation in essential hypertension by calcium channel blockade with verapamil.

Authors:  U L Hulthén; P Bolli; F W Amann; W Kiowski; F R Bühler
Journal:  Hypertension       Date:  1982 May-Jun       Impact factor: 10.190

View more
  13 in total

Review 1.  Arterial compliance and blood pressure.

Authors:  S J Marchais; A P Guerin; B Pannier; G Delavaud; G M London
Journal:  Drugs       Date:  1993       Impact factor: 9.546

Review 2.  Heterogeneity of response of peripheral arteries to antihypertensive drugs in essential hypertension. Basic effects and functional consequences.

Authors:  J Levenson; A Simon
Journal:  Drugs       Date:  1988       Impact factor: 9.546

3.  Complex effects of Gillichthys urotensin II on rat aortic strips.

Authors:  A Gibson
Journal:  Br J Pharmacol       Date:  1987-05       Impact factor: 8.739

4.  Effect of nicardipine in elderly hypertensive patients.

Authors:  F Forette; M Bellet; J F Henry; M P Hervy; C Poyard-Salmeron; P Bouchacourt; M Guerret
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

5.  Antihypertensive effect of slow-release nicardipine. A placebo-controlled cross-over study.

Authors:  A Salvetti; G Cardellino; M Pesenti; A Caiazza; F Ghisoni; C Del Prato; P F Innocenti; F Ponzanelli; M Errico; M Freda
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 6.  Nicardipine. A review of its pharmacology and therapeutic efficacy in older patients.

Authors:  J E Frampton; D Faulds
Journal:  Drugs Aging       Date:  1993 Mar-Apr       Impact factor: 3.923

Review 7.  Nicardipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in the treatment of angina pectoris, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold
Journal:  Drugs       Date:  1987-04       Impact factor: 9.546

Review 8.  Cardiac hypertrophy and aortic compliance after calcium channel antagonism in hypertension.

Authors:  B M Pannier; J L Tual; M E Safar
Journal:  Drugs       Date:  1992       Impact factor: 9.546

9.  Amlodipine induces a flow and pressure-independent vasoactive effect on the brachial artery in hypertension.

Authors:  J L Megnien; J Levenson; M Del-Pino; A Simon
Journal:  Br J Clin Pharmacol       Date:  1995-06       Impact factor: 4.335

10.  Changes in the haemodynamics of large arteries induced by single doses of nicardipine, enalapril, atenolol and urapidil.

Authors:  P Pancera; E Arosio; F Priante; M Ribul; M Zannoni; G Talamini; A Lechi
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.